Acquisition

A new wave of AI builds entire enterprise apps, but can it be trusted? WaveMaker's early success suggests its architecture-first approach is the key.

GMEX Robotics' first deployment of its Bon Vivant 3.0 cooking robots marks a new era for Australia's hospitality industry, blending AI with culinary arts.

Arctera shifts to a unified SaaS model, promising limitless scale for data compliance. What does this strategic pivot mean for enterprises and the market?

Experts predict a hyperactive hurricane season. Learn why the threat is rising and how to protect your property before the first storm makes landfall.

NImmune Biopharma's oral drug NIM-1324 shows promising safety and efficacy, targeting a novel pathway to treat IBD and a host of other diseases.

A new partnership offers employees interest-free financing for out-of-pocket medical costs, tackling a key barrier to care and boosting employer benefits.

A historic 142 deals and $1.67 trillion in assets changed hands in Q1 2026, as private equity, tech, and global ambitions fuel a record consolidation wave.

Viant's acquisition of TVision challenges industry giants by pricing TV ads on actual viewership, moving beyond impressions to verifiable human attention.

The global investment bank is buying the boutique firm behind landmark deals for Liverpool FC and the NY Mets to dominate the booming sports finance market.

Sensei Biotherapeutics begins a key trial for PIKTOR, a novel oral therapy aiming to outsmart cancer resistance in patients with advanced breast cancer.

Minerva Neurosciences launches a pivotal Phase 3 trial for roluperidone, a potential first-in-class drug for the untreated negative symptoms of schizophrenia.

With veteran Jason Montrie at the helm, Alerion Advisors aims to build an integrated platform to solve health plans' biggest operational headaches.

HealthVerity's acquisition of Symphony Health unites clinical and commercial data, promising to shatter industry silos and accelerate medical breakthroughs.

Following a key Gartner recognition, Aegis Software is integrating digital twins and AI to move factories from reactive execution to predictive intelligence.

In a market focused on scale, Silvester & Company's acquisition of ChampionScott Partners signals a strategic shift toward specialized, future-focused leadership.

AcreTrader's latest deal delivered big returns for investors and let a local family buy the land. Is this a new model for harmony or just a new land rush?

With new COO Sarah Campbell and fresh capital, Future Technologies is scaling aggressively to solve the critical 'AI Connectivity Gap' for major industries.

As AI fakes threaten truth, Reality Defender recruits pioneers from Google, Twitter, and academia to build an ethical framework for detection technology.

A new biotech emerges with a promising, late-stage gene therapy for Sanfilippo syndrome, offering a potential lifeline for children with no other options.

Atkore's Q2 revenue rose 4.2%, but a $136.5M antitrust settlement drove a major net loss. The company divests assets to focus on its electrical core.